Citation: H. Holzgreve, PLACE OF CALCIUM-ANTAGONISTS IN COMBINATI ON WITH ACE-INHIBITORS IN RISK MANAGEMENT OF HYPERTENSIVE PATIENTS, Perfusion, 11(5), 1998, pp. 232-233
Citation: H. Holzgreve, LONG-TERM EFFICACY AND SAFETY OF CANDESARTAN CILEXETIL IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27101-27101
Authors:
PHILIPP T
ANLAUF M
DISTLER A
HOLZGREVE H
MICHAELIS J
WELLEK S
Citation: T. Philipp et al., RANDOMIZED, DOUBLE-BLIND, MULTICENTER COMPARISON OF HYDROCHLOROTHIAZIDE, ATENOLOL, NITRENDIPINE, AND ENALAPRIL IN ANTIHYPERTENSIVE TREATMENT - RESULTS OF THE HANE STUDY, BMJ. British medical journal, 315(7101), 1997, pp. 154-159
Citation: P. Sever et H. Holzgreve, LONG-TERM EFFICACY AND TOLERABILITY OF CANDESARTAN CILEXETIL IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Journal of human hypertension, 11, 1997, pp. 69-73
Authors:
MIDDEKE M
RICHTER WO
SCHWANDT P
HOLZGREVE H
Citation: M. Middeke et al., THE EFFECTS OF ANTIHYPERTENSIVE COMBINATION THERAPY ON LIPID AND GLUCOSE-METABOLISM - HYDROCHLOROTHIAZIDE PLUS SOTALOL VS HYDROCHLOROTHIAZIDE PLUS CAPTOPRIL, International journal of clinical pharmacology and therapeutics, 35(6), 1997, pp. 231-234
Authors:
KRIBBEN A
ANLAUF M
DISTLER A
GARTNER H
HOLZGREVE H
MICHAELIS J
ROCKER L
SCHAFERS R
PHILIPP U
WELLEK S
PHILIPP T
Citation: A. Kribben et al., HYDROCHLOROTHIAZIDE, ATENOLOL, NITRENDIPINE, AND ENALAPRIL IN ANTIHYPERTENSIVE TREATMENT - INFLUENCE ON LVH, PROTEINURIA AND METABOLIC PARAMETERS, Kidney international, 1997, pp. 74-76
Authors:
KEUNEKE C
BRUMBERGER V
MASTELLOTTO A
FISCHEREDER M
MIDDEKE M
DUHM J
HOLZGREVE H
Citation: C. Keuneke et al., SODIUM-LITHIUM-COUNTERTRANSPORT-ACTIVITY IS ALREADY ELEVATED IN WHITECOAT HYPERTENSION, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1507-1507
Authors:
KEUNEKE C
DUHM J
REDER S
BRUCKNER W
BRUMBERGER V
MASTELOTTO A
FISCHEREDER M
MIDDEKE M
HOLZGREVE H
Citation: C. Keuneke et al., ARE BOTH WHITE COAT HYPERTENSION AND SODIUM-LITHIUM COUNTERTRANSPORT-ACTIVITY (SLC) IMPORTANT FACTORS FOR THE DEVELOPMENT OF HYPERTENSION, Kidney international, 50(5), 1996, pp. 1801-1801
Citation: A. Schrey et H. Holzgreve, MULTIFACTORIAL INTERVENTIONS IN CARDIOVAS CULAR-DISEASE - PRESS-CONFERENCE WITH HOLZGREVE,HEINRICH, Herz, Kreislauf, 28(12), 1996, pp. 5
Citation: J. Lorenzen et H. Holzgreve, HELPING PARENTS TO GRIEVE AFTER 2ND-TRIMESTER TERMINATION OF PREGNANCY FOR FETOPATHIC REASONS, Fetal diagnosis and therapy, 10(3), 1995, pp. 147-156
Authors:
SCHUSTER H
WIENKER TF
MIDDEKE M
HOLZGREVE H
LUFT FC
Citation: H. Schuster et al., ASSOCIATION OF ANGIOTENSIN-CONVERTING ENZYME (ACE) POLYMORPHISMS IN AGERMAN HYPERTENSIVE POPULATION, Journal of the American Society of Nephrology, 5(3), 1994, pp. 567-567
Citation: Fr. Buhler et al., CARDIOVASCULAR REMODELING AND ITS CORRECTION - TOWARD A COMPREHENSIVESTRATEGY, The American journal of medicine, 94, 1993, pp. 1-3